Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it mattersMarkus Ketteler, Mary B. Leonard, Nigel D. Toussaint et al.|Kidney International|2017Cited by 998
Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline UpdateMarkus Ketteler, Mary B. Leonard, Geoffrey A. Block et al.|Annals of Internal Medicine|2018Cited by 316
Effect of Vitamin K2 Supplementation on Functional Vitamin K Deficiency in Hemodialysis Patients: A Randomized TrialRalf Westenfeld, Leon J. Schurgers, Thilo Krueger et al.|American Journal of Kidney Diseases|2011Cited by 293
Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patientsJürgen Floege, Adrian Covic, Markus Ketteler et al.|Nephrology Dialysis Transplantation|2015Cited by 142
Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcificationMiguel D. Ferrer, Joan Perelló, Markus Ketteler et al.|PLoS ONE|2018Cited by 51